Studies on the Micrografting Technology of Grape (Vitis vinifera L.)

Hou-nan Cao,Bo Zhu,Cheng-Wen Zong,Ri-Zi Piao,Yi-Long Piao 한국원예학회 2006 한국원예학회 기타간행물 Vol.- No.-

Nanowire interface doping

Nan PAN,Yiming WU,Siwen ZHAO,Huaiyi DING,Xiaoping WANG,Yi LUO,J. G. HOU 한국진공학회 2016 한국진공학회 학술발표회초록집 Vol.2016 No.8

Sports impact on the nanomedicine absorption in drug delivery

Mengqian Hou,Xin Fang,Teng Nan Techno-Press 2023 Advances in nano research Vol.14 No.2

Physical activities enhance blood flow in the vessels, which may increase the quality of medicine delivery. The emergence of revolutionary technologies such as nanoscience, made it possible to treat the incurable illnesses such as cancer. This paper investigates the impact of sport and physical exercises on the quality and quantity of the drug-delivery based on the mathematical modeling of a nanomotor made by nanotubes carrying the nano-drug capsules. Accordingly, the mathematical equations of rotating nanomotor are generated by considering the both of higher-order beam model and nonlocal strain gradient model, as a comprehensive continuum theory. Next, through the generalized differential quadrature together with Newmark-beta methods, the differential relations are discretized and solved. Finally, the impact of varied parameters on the dynamical behavior of the nanomotor is examined in detail. The outcomes of this investigation can be useful to achieve an excellent design of nanomotors carrying nano-drugs.

Ginsenoside Rh2 Improves Learning and Memory in Mice

Jingang Hou,Jian Jie Xue,이미라,Lei Liu,Dong-Liang Zhang,Mengqi Sun,Yi-nan Zheng,성창근 한국식품영양과학회 2013 Journal of medicinal food Vol.16 No.8

A wide range of plant foods and dietary supplements are able to modify the functioning of the central nervous system. In the present study, we observed that oral administration of ginsenoside Rh2 (10 mg/mL) for 3 weeks significantly improved spatial learning and memory. Spatial memory and learning was evaluated in mice by hippocampus-dependent tasks (Morris water maze test) and immunohistochemical marker of cell genesis bromodeoxyuridine. Ginsenoside Rh2 treatment (30 days) promoted cell survival and genesis. Further, ginsenoside Rh2 treatment in enriched condition had no significant effects on cell survival compared with standard condition exposure. These results revealed that ginsenoside Rh2-mediated spatial learning and memory improvement was associated with cell genesis and survival and may be parallel to the mechanism of environmental enrichment. Therefore, ginsenoside Rh2 may have efficacy as a dietary supplement for spatial learning and memory improvement.

Phtotoelectrochemical water oxidation to H2O2 based on N-TiO2 derived from NH2-MIL-125 and in-situ application on degradation dye

Kunpeng Liu,Nan Wang,Jianhua Li,Fanglin Du,Baorong Hou,Ruiyong Zhang 한국공업화학회 2023 Journal of Industrial and Engineering Chemistry Vol.128 No.-

Electrochemical two-electron water oxidation reaction (2e WOR) to produce H2O2 has been widely concerned. However, four-electron competition reaction causes the large overpotential and low productionrates of 2e WOR, which restrict its’ development and application. Herein, we prepared N-TiO2 derivedfrom NH2-MIL-125 by the hydrothermal combined with calcination method. We found that N-TiO2 asphotoanode exhibited the well properties of photoelectrocatalysis water oxidation, which gave an overpotentialof 630 mV at 1 mA cm2. The overpotentials of N-TiO2 was approximately 130 mV (at1 mA cm2) lower than NH2-MIL-125, and even lower than the previous reported TiO2, which may attributeto the increased oxygen vacancy with the calcination process and N doping. In addition, we investigatedthe degradation performance of the prepared catalysts to degrade methylene blue byphotoelctrocatalysis on-site the preparation of H2O2. It was shown that N-TiO2 performed high degradationefficiency (91%) and excellent stability. The possible mechanism was speculated due to theincreased oxygen vacancy and N doping. This work provides a new idea for photoelectrocatalysis wateroxidation materials and points out a new way for on-site H2O2 production for direct use

Structure-based design, structure–activity relationship analysis, and antitumor activity of diaryl ether derivatives

Shao-Mei Yang,Fu-Nan Li,Zhi-Ning Huang,Zhong-Shi Zhou,Jin Hou,Man-Yi Zheng,Li-Juan Wang,Yu Jiang,Xin-Yi Zhou,Qiu-Yue Chen,Shan-Hua Li 대한약학회 2015 Archives of Pharmacal Research Vol.38 No.10

To identify novel therapeutic agents to treatcancer, we synthesized a series of diaryl ether derivatives. Structure–activity relationship studies revealed that thepresence of a chlorine or hydroxyl at the para-position onthe phenyl ring (5h or 5k) significantly enhanced antitumoractivity. Compound 5h had stronger growth inhibitory activityin HepG2, A549, and HT-29 cells than compound 5k,with IC50 values of 2.57, 5.48, and 30.04 lM, respectively. Compound 5h also inhibited the growth of other cells lines,including Hep3B, PLC/PRF5, SMMC-7721, HeLa, andA375, with IC50 values of 2.76, 4.26, 29.66, 18.86, and10.21 lM, respectively. The antitumor activity of compound5h was confirmed by a colony forming assay. Further,our results indicated that the antitumor activity ofcompound 5h may be mediated by enhancing expression ofp21 and cl-caspase3, and leading to apoptosis of cancercells.

Compound glycyrrhizin injection for improving liver function in children with acute icteric hepatitis: A systematic review and meta-analysis

Liang Shi-Bing,Hou Wen-Bin,Zheng Ruo-Xiang,Liang Chang-Hao,Yan Li-Jiao,Wang Hao-Nan,Cao Hui-Juan,Han Mei,Robinson Nicola,Liu Jian-Ping 한국한의학연구원 2022 Integrative Medicine Research Vol.11 No.1

Background: Compound glycyrrhizin injection (CGI) is a preparation with glycyrrhizin as the main active ingredient extracted from licorice. As clinical trials suggest that CGI is effective in improving liver function for acute icteric hepatitis in children (AIHC), this systematic review aimed to evaluate and verify its therapeutic effects and safety. Methods: Six electronic databases were searched from their inception to 15 May 2021. Randomized controlled trials (RCTs) assessing therapeutic effects and safety of CGI for AIHC were included. The risk of bias for each trial was assessed using the Cochrane Risk of Bias Tool 2.0. Primary outcomes were indexes related to liver function, including total bilirubin (TBiL), alanine aminotransferase (ALT) and aspartate transaminase (AST). RevMan 5.4 software was used for data analyses. The certainty of the evidence was assessed using the online GRADEpro tool. Results: Six RCTs involving 608 children were included. The overall bias was assessed as having “high risk of bias” in all trials. All trials compared the combination of CGI and conventional western medicine (CWM) with CWM alone. Regarding the effects of CGI for AIHC, results showed that CGI plus CWM was superior to CWM alone in reducing the levels of TBiL (mean difference (MD) = -8.19 mmol/L, 95% CI -9.86 to -6.53), ALT (MD = -24.09 U/L, 95% CI -30.83 to -17.34) and AST (MD = -18.67 U/L, 95% CI -21.88 to -15.45). No trial reported adverse events. The certainty of the evidence for outcomes were all evaluated as low or very low. Conclusion: CGI may have adjuvant therapeutic effects on improving the liver function of children with AIHC. There is no evidence to determine the safety of CGI for AIHC. As current evidence is weak, further well-designed RCTs are required for verification of the therapeutic effects of CGI. Background: Compound glycyrrhizin injection (CGI) is a preparation with glycyrrhizin as the main active ingredient extracted from licorice. As clinical trials suggest that CGI is effective in improving liver function for acute icteric hepatitis in children (AIHC), this systematic review aimed to evaluate and verify its therapeutic effects and safety. Methods: Six electronic databases were searched from their inception to 15 May 2021. Randomized controlled trials (RCTs) assessing therapeutic effects and safety of CGI for AIHC were included. The risk of bias for each trial was assessed using the Cochrane Risk of Bias Tool 2.0. Primary outcomes were indexes related to liver function, including total bilirubin (TBiL), alanine aminotransferase (ALT) and aspartate transaminase (AST). RevMan 5.4 software was used for data analyses. The certainty of the evidence was assessed using the online GRADEpro tool. Results: Six RCTs involving 608 children were included. The overall bias was assessed as having “high risk of bias” in all trials. All trials compared the combination of CGI and conventional western medicine (CWM) with CWM alone. Regarding the effects of CGI for AIHC, results showed that CGI plus CWM was superior to CWM alone in reducing the levels of TBiL (mean difference (MD) = -8.19 mmol/L, 95% CI -9.86 to -6.53), ALT (MD = -24.09 U/L, 95% CI -30.83 to -17.34) and AST (MD = -18.67 U/L, 95% CI -21.88 to -15.45). No trial reported adverse events. The certainty of the evidence for outcomes were all evaluated as low or very low. Conclusion: CGI may have adjuvant therapeutic effects on improving the liver function of children with AIHC. There is no evidence to determine the safety of CGI for AIHC. As current evidence is weak, further well-designed RCTs are required for verification of the therapeutic effects of CGI.

Evaluation of the 2.5-km Cloud-Resolving Storm Simulator in Predicting Local Afternoon Convection during the Summer in Taiwan

Chung-Chieh Wang,Nan-Chou Su,Jou-Ping Hou,이동인 한국기상학회 2018 Asia-Pacific Journal of Atmospheric Sciences Vol.54 No.3

The forecast of summertime afternoon convection by numerical weather prediction models is highly challenging because of its weak dynamical forcing, small scale, and low predictability. To assess such an ability for future improvement, we evaluated the performance of the 2.5-km Cloud-Resolving Storm Simulator (CReSS) in predicting afternoon convection in Taiwan under weak synoptic conditions during the summers (May–October) of 2011 and 2012. For a total of 89 target days, daily CReSS forecasts in three ranges, starting at 0000 UTC (0800 LST) on the same day (D0), the day before (D-1), and 2 days before (D-2), were examined. With regard to the occurrence of afternoon convection anywhere in Taiwan, the predictive skill of the model was considerably high, as evidenced by the threat score (TS) and post-agreement (PA) of D0 (D-1) forecasts reaching 0.75 and 0.90 (0.50 and 0.79), respectively.While the score values decrease when Taiwan is divided into four regions (i.e., the forecast must be in the correct region to be considered a hit), the TS and PA for D0 (D-2) forecasts remain respectable at 0.44 and 0.73 (0.29 and 0.59). Among the four regions, the TS (0.48–0.65) and PA (0.77–0.83) for Central Taiwan are the highest with the best predictive skill. Overall, while the prediction of afternoon convection in the correct region is challenging, the 2.5-km CReSS model has considerable skill (TS ~ 0.30) even 2 days in advance, and can provide useful guidance for afternoon convection in Taiwan.

Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

( Lai Wei ),( Qing Xie ),( Jin Lin Hou ),( Hong Tang ),( Qin Ning ),( Jun Cheng ),( Yuemin Nan ),( Lunli Zhang ),( Jun Li ),( Jianning Jiang ),( Megan Kim ),( Brian Mcnabb ),( Fangqiu Zhang ),( Gregor 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1

Aims: Chronic hepatitis C virus (HCV) infection remains a major health threat in China, affecting at least 10 million people, with approximately 58% having genotype (GT) 1 infection. There is a critical need for simple, all oral, direct-acting antiviral regimens to treat GT1 HCV in this region. Treatment with ledipasvir (LDV)/sofosbuvir (SOF) results in high sustained virologic response rates 12 weeks after therapy (SVR12) in GT1 HCV infected patients in clinical trials and real-world settings. This study evaluated the efficacy and safety of LDV/SOF for 12 weeks in Chinese patients with chronic GT1 HCV infection. Methods: Treatment experienced and treatment naïve patients with chronic GT1 HCV infection with no cirrhosis or with compensated cirrhosis were eligible to enroll in a single-arm, openlabel trial to receive a fixed dosed combination of LDV/SOF 90/400 mg daily for 12 weeks. The primary efficacy endpoint was SVR12 using the CAP/CTM HCV 2.0 assay (LLOQ =15 IU/mL) and the primary safety endpoint was adverse events (AEs) leading to LDV/SOF discontinuation. Results: A total of 206 Chinese patients were enrolled and treated. Of these, 50% were male, 16% had compensated cirrhosis, 49% were treatment-experienced, 76% had IL28B CC genotype, and 100% had GT1b HCV infection. The mean (range) age and body mass index of enrolled subjects were 47 (21-72) years and 23 (14-34) kg/m2, respectively. The overall SVR12 rate is 100% (206/206). All 32 patients with cirrhosis (15 of whom were treatment-experienced), achieved SVR12. There were no discontinuations due to AEs. No serious or severe AEs were assessed by the investigator as related to study drug and there were no deaths. Conclusions: Treatment with the single tablet regimen of LDV/SOF for 12 weeks resulted in 100% SVR12 and was well tolerated in treatment experienced and treatment naïve GT1 HCVinfected Chinese patients with and without cirrhosis.

In Vivo Detection of Lipid-Core Plaques by Coronary CT Angiography: A Head-to-Head Comparison with Histologic Findings

Wei-hua Yin,Yan Zhang,Xiang-nan Li,Hong-yue Wang,Yun-qiang An,Yang Sun,Zhi-hui Hou,Yang Gao,Bin Lu,Zhe Zheng 대한영상의학회 2020 Korean Journal of Radiology Vol.21 No.2

Objective: We sought to distinguish lipid plaques using a CT quantitative pixel density histogram, based on the pathological diagnosis of lipid cores as the gold standard. Materials and Methods: Eight patients awaiting heart transplantation due to end-stage coronary heart disease underwent coronary CT angiography (CCTA) spectroscopy prior to heart transplantation; coronary artery pathological analysis was performed for all patients. Lipid-core plaques were defined pathologically as manifesting a lipid core diameter > 200 μm, a circumference > 60 degrees, and a cap thickness < 450 μm. The percentage distributions of CT pixel attenuation ≤ 20, 30, 40, and 50 HU were calculated using quantitative histogram analysis. Results: A total of 271 transverse sections were co-registered between CCTA and pathological analysis. Overall, 26 lipid cores and 16 fibrous plaques were identified by pathological analysis. There was no significant difference in median CT attenuation between the lipid and fibrous plaques (51 HU [interquartile range, 46–63] vs. 57 HU [interquartile range, 50–64], p = 0.659). The median percentage of CT pixel attenuation ≤ 30 HU accounted for 11% (5–17) of lipid-core plaques and 0% (0–2) of fibrous plaques (p < 0.001). The sensitivity and specificity of the method for diagnosing lipid plaques by the average CT pixel attenuation ≤ 30 HU were 80.8% and 87.5%, respectively. The area under the receiver operator characteristics curve was 0.898 (95% confidence interval: 0.765–0.970; 3.0% was the best cut-off value). The diagnostic performance was significantly higher than those of the average pixel CT attenuation percentages ≤ 20, 40, and 50 HU and the mean CT attenuation (p < 0.05). Conclusion: In in vivo conditions, with the pathological lipid core as the gold standard, quantification of the percentage of average CT pixel attenuation ≤ 30 HU in the histogram can be useful for accurate identification of lipid plaques.